AMBRY GENETICS Products & Brands - Key Offerings and Insights

Products

Category

Product

Brand

Description

Rare Disease Diagnostics (PHM227B)

Clinical genomic testing services		offer a comprehensive screening and diagnosis test menu for a range of conditions, including hereditary cancer, hereditary cardiovascular disease, neurodevelopmental disorders, epilepsy, rare diseases, and exome.
+RNAinsight		Add simultaneous RNA genetic testing to DNA tests to provide more accurate, actionable results.
ExomeNext		ExomeNext platform covers the entire genome and includes options for analyzing 500 to 20,000 genes and the mitochondrial genome.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.